A 7-year 6-month-old, castrated male Shiba dog presented with a 1-month history of
lethargy, anorexia, vomiting, and frequent watery diarrhea. Weight loss, hypoalbuminemia,
anemia, and leukocytosis were detected at the first visit. The dog was diagnosed with
non-responsive enteropathy (NRE) based on clinical and histopathological examinations.
Since the dog did not respond to the immunosuppressive drugs, fecal microbiota
transplantation (FMT) was performed during the treatment with chlorambucil. A single
endoscopic FMT into the cecum and colon drastically recovered clinical signs and
clinicopathological abnormalities and corrected dysbiosis in the dog. No recurrence or
adverse events were observed. The present case report suggests that FMT, possibly together
with chlorambucil, might be a treatment option for NRE in Shiba dogs that have poorer
prognosis compared with other dog breeds.
Inflammasomes play a pivotal role in gastrointestinal homeostasis and inflammation. However, it remains elusive whether the nucleotide-binding oligomerization domain-like receptor (NLR) family inflammasomes, such as NLR family pyrin domain-containing (NLRP)3, NLRP6, and NLRP12, are involved in the pathogenesis of canine chronic enteropathy (CE), which includes antibiotic-responsive enteropathy (ARE), food-responsive enteropathy (FRE), immunosuppressant-responsive enteropathy (IRE), and non-responsive enteropathy (NRE). Thus, we measured mRNA expression of NLRP3, NLRP6, and NLRP12 in the intestinal mucosa of 35 dogs with CE (ARE, four dogs; FRE, 11 dogs; IRE and NRE, 20 dogs) and seven healthy dogs. As per real-time PCR analysis, significant increases in mRNA expression of NLRP3 and NLRP12 were noted in the colonic but not in the duodenal mucosa of dogs with FRE compared to healthy dogs. These findings suggested that the NLRP3 and NLRP12 inflammasomes might contribute to the development of colitis in dogs with FRE.
Background -The involvement of interleukin (IL)-33 produced by keratinocytes has been suggested in the pathogenesis of canine atopic dermatitis (cAD). House dust mite (HDM)-derived proteases induce the production of various cytokines and chemokines in keratinocytes via protease-activated receptor-2 (PAR-2); however, their effects on IL-33 mRNA expression in canine keratinocytes have not been determined.Hypothesis/Objective -To clarify whether HDM-derived proteases induce IL-33 mRNA expression in canine keratinocytes via PAR-2.Methods and materials -Expression of IL-33 mRNA was quantified by real-time PCR in a cell line of canine progenitor epidermal keratinocytes (CPEK) stimulated with Dermatophagoides farinae (Der f) whole body extract, Der f pre-treated with cysteine protease and serine protease inhibitors, and trypsin. Trypsin and Der f-mediated IL-33 mRNA expression also was measured in CPEK cells treated with a PAR-2 antagonist.Results -Der f enhanced IL-33 mRNA expression in CPEK cells in incubation time-and dose-dependent manners. Der f pre-treated with a serine protease inhibitor, and not a cysteine protease inhibitor, abrogated an increase in IL-33 mRNA expression in CPEK cells. Trypsin also enhanced IL-33 mRNA expression in CPEK cells. Trypsin-mediated IL-33 mRNA expression was completely abolished by a PAR-2 antagonist, while Der fmediated IL-33 mRNA expression was partially and significantly diminished by it.Conclusions and clinical relevance -Der f-derived serine protease upregulated IL-33 mRNA expression in CPEK cells at least in part via PAR-2. These findings suggest that HDM may be involved in the development of C AD by increasing IL-33 mRNA expression in keratinocytes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.